Functional Foods in Complex Treatment of Patients with Metabolic Syndrome
Journal Title: Міжнародний ендокринологічний журнал - Year 2013, Vol 3, Issue 51
Abstract
Functional foods are intended for a systematic daily consumption and have a regulating effect on physiological functions, biochemical reactions and psychosocial behavior due to the normalization of microecological status. Objective of the study — improving the efficiency of complex treatment of patients with metabolic syndrome by the use of dietary supplements BioSESS. Materials and Methods. 26 patients with metabolic syndrome (I stage obesity, arterial hypertension, lipid disorders, impaired glucose tolerance) were examined. BioSЕSS was administered for 4 capsules 2 times a day during 10 days, in 20 days after completion of the first course the second one was administered in a similar way. Comparison group consisted of 14 patients with metabolic syndrome, who hadn’t receive BioSESS in complex treatment. Results of the Study. Significant and statistically reliable decrease of insulin resistance in peripheral tissues was noted. НОМА-IR index decreased significantly — from 6.58 ± 0.92 to 3.44 ± 0.86. There is observed significant reduction in total cholesterol content by 13.1 % from initial data — 6.18 ± 0.24 mmol/l to 5.46 ± 0.22 mmol/l (р < 0.05), very low density lipoproteins — by 36.2 %, from 0.79 ± 0.07 mmol/l to 0.58 ± 0.06 mmol/l (р < 0.05), low density lipoproteins — by 5.9 %, from 3.98 ± 0.16 mmol/l to 3.56 ± ± 0.18 mmol/l (p < 0.05), triglycerides — by 37.2 %, from 1.77 ± ± 0.19 mmol/l to 1.29 ± 0.14 mmol/l (р < 0.05). The combined therapy assisted more significant decrease in C-reactive protein (СRP) level (from 6.91± 0.66 mg/dl to 4.83 ± 0.58 mg/dl) compared to control group (by 31.2 and 23.1 %, respectively, p < 0.05). Conclusions. Application of BioSESS in complex therapy of patients with metabolic syndrome for certain improves the indexes of lipid metabolism, reduces hyperinsulinemia and concomitant insulin resistance. The use of BioSESS in complex therapy of patients with metabolic syndrome promotes the decline of blood pressure level in day time, improvement of diastolic function of myocardium. In patients with metabolic syndrome BioSESS has useful pleiotropic effects that are manifested in the significant decrease of CRP levels in the blood by 31.2 % (p < 0.05).
Authors and Affiliations
V. I. Pankiv, S. M. Yurchak
Keywords
Related Articles
- EP ID EP233023
- DOI -
- Views 72
- Downloads 0
Analysis of Changes of Diabetes Care Quality under Implementation of Unified Clinical Pathway for Caring Diabetic Type 2 Patients
After the adoption of a unified clinical pathway for diabetes mellitus type 2 care in 2012 in Ukraine it is relevant to analyze the results of its implementation and the quality of diabetes care. The aim is to analyze th...
Peculiarities of Lipid Metabolism in Patients with Prolactinomas during Suppressive Dopamine Agonist Therapy
The article presents the data of lipid metabolism at the stages of long-term (12 months) suppressive therapy with dopamine agonist cabergoline in 61 patients with prolactinoma. It is proved that the normalization of prol...
Benfotiamine and Alpha-Lipoic Acid in the Treatment of Diabetic Cardiovascular Autonomic Neuropathy (Review of Literature and Own Researches)
The analysis of current views on the mechanisms of fat-soluble form of vitamin B1 (benfotiamine) and α-lipoic acid action, in particular features of their impact on carbohydrate and lipid metabolism, endothelial function...
Effect of Combination Therapy with Alpha-Lipoic Acid on the Fractalkine Level in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus
Background. The aim of research — to assess the fractalkine levels in patients with coronary artery disease (CAD), depending on the presence of type 2 diabetes mellitus (DM) and the nature of coronary artery lesions bef...
A1chieve® Study: Global problems of Compensation of Diabetes Mellitus Type 2
No abstract